Teladoc Health Inc (TDOC)
13.30
+0.32
(+2.47%)
USD |
NYSE |
Apr 22, 16:00
13.32
+0.02
(+0.15%)
Pre-Market: 05:24
Teladoc Health Debt to Equity Ratio: 0.6615 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2023 | 0.6615 |
September 30, 2023 | 0.6704 |
June 30, 2023 | 0.6697 |
March 31, 2023 | 0.6704 |
December 31, 2022 | 0.6653 |
September 30, 2022 | 0.2535 |
June 30, 2022 | 0.252 |
March 31, 2022 | 0.1677 |
December 31, 2021 | 0.0764 |
September 30, 2021 | 0.0758 |
June 30, 2021 | 0.0751 |
March 31, 2021 | 0.0855 |
December 31, 2020 | 0.0895 |
September 30, 2020 | 0.4274 |
June 30, 2020 | 0.7322 |
March 31, 2020 | 0.4471 |
December 31, 2019 | 0.4343 |
September 30, 2019 | 0.4365 |
June 30, 2019 | 0.4261 |
Date | Value |
---|---|
March 31, 2019 | 0.4202 |
December 31, 2018 | 0.4093 |
September 30, 2018 | 0.3976 |
June 30, 2018 | 0.5759 |
March 31, 2018 | 0.382 |
December 31, 2017 | 0.371 |
September 30, 2017 | 0.8311 |
June 30, 2017 | 0.6105 |
March 31, 2017 | 0.1236 |
December 31, 2016 | 0.1924 |
September 30, 2016 | 0.1835 |
June 30, 2016 | 0.2065 |
March 31, 2016 | 0.1587 |
December 31, 2015 | 0.1483 |
September 30, 2015 | 0.1408 |
June 30, 2015 | 0.7798 |
March 31, 2015 | 0.6297 |
December 31, 2014 | 0.4861 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0751
Minimum
Jun 2021
0.7322
Maximum
Jun 2020
0.3851
Average
0.4274
Median
Sep 2020
Debt to Equity Ratio Benchmarks
Omnicell Inc | 0.4791 |
Phreesia Inc | 0.0125 |
10x Genomics Inc | 0.00 |
Biote Corp | -3.840 |
American Shared Hospital Services | 0.7773 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 4.392B |
Total Liabilities (Quarterly) | 2.066B |
Shareholders Equity (Quarterly) | 2.326B |
Current Ratio | 3.540 |
Net Debt Paydown Yield | -0.02% |